Publicacions en què col·labora amb Pablo Sarobe Ugarriza (9)

2023

  1. Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma

    Nature Medicine, Vol. 29, Núm. 3, pp. 632-645

2015

  1. Radioembolization of hepatocellular carcinoma activates liver regeneration, induces inflammation and endothelial stress and activates coagulation

    Liver International, Vol. 35, Núm. 5, pp. 1590-1596

2012

  1. Combination of a TLR4 ligand and anaphylatoxin C5a for the induction of antigen-specific cytotoxic T cell responses

    Vaccine, Vol. 30, Núm. 18, pp. 2848-2858

2005

  1. Is plasma cardiotrophin-1 a marker of hypertensive heart disease?

    Journal of Hypertension, Vol. 23, Núm. 3, pp. 625-632

1999

  1. Synthesis and anti-HIV-1 activities of new pyrimido[5,4-b]indoles

    Farmaco, Vol. 54, Núm. 4, pp. 255-264

  2. T(h)1 but not T(h)0 cell help is efficient to induce cytotoxic T lymphocytes by immunization with short synthetic peptides

    International Immunology, Vol. 11, Núm. 12, pp. 2025-2033

1997

  1. Synthesis and evaluation of new Reissert analogs as HIV-1 RT inhibitors. 2. Benzo[f]quinoline and pyridine derivatives

    Drug Design and Discovery, Vol. 14, Núm. 4, pp. 291-303

  2. Synthesis and evaluation of new Reissert analogs as HIV-1 reverse transcriptase inhibitors. 1. Quinoline and quinoxaline derivatives

    Drug Design and Discovery, Vol. 14, Núm. 4, pp. 305-332

1995

  1. Indoles and pyridazino[4,5-b]indoles as nonnucleoside analog inhibitors of HIV-1 reverse transcriptase

    European Journal of Medicinal Chemistry, Vol. 30, Núm. 12, pp. 963-971